PARP1 and inflammatory bowel disease: Oxidative damage during the pathogenesis of IBD is known to promote structural alterations in DNA (49–51), and PARP1 activation has been shown to be increased within the intestinal mucosa of mice subjected to experimental colitis and in humans with UC (68–71).